Daiwa Securities Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Daiwa Securities Group’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-185	Closed	-$14K	–	1440
2022 Q2	$14K	Buy	185 +41	+28%	+$1.82K	﹤0.01%	1131
2022 Q1	$4K	Hold	144	–	–	﹤0.01%	1206
2021 Q4	$7K	Sell	144 -25	-15%	-$1.12K	﹤0.01%	1177
2021 Q3	$11K	Buy	169 +74	+78%	+$5.27K	﹤0.01%	1134
2021 Q2	$7K	Hold	95	–	–	﹤0.01%	1062
2021 Q1	$9K	Buy	95 +4	+4%	+$476	﹤0.01%	1049
2020 Q4	$11K	Sell	91 -144	-61%	-$15.8K	﹤0.01%	1016
2020 Q3	$21K	Buy	235 +33	+16%	+$2.3K	﹤0.01%	988
2020 Q2	$9K	Hold	202	–	–	﹤0.01%	1076
2020 Q1	$9K	Hold	202	–	–	﹤0.01%	1067
2019 Q4	$13K	Buy	+202	New	+$9.61K	﹤0.01%	1041

Daiwa Securities Group's TPTX Position: Q3 2022 in Review

Daiwa Securities Group sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 185 shares — an estimated $14K sold.

Daiwa Securities Group first reported a position in TPTX in Q4 2019 and held it in 11 quarters. The position peaked at $21K in Q3 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Daiwa Securities Group reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Daiwa Securities Group sold 185 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $14K.
Daiwa Securities Group first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
Daiwa Securities Group's Turning Point Therapeutics, Inc. Common Stock position peaked at $21K in Q3 2020.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Daiwa Securities Group's 13F filing for Q3 2022, filed 2 Nov 2022.